Stock listing

NYSE American:RGNT Regentis Biomaterials Ltd. Stock

Home listing (NYSE American) of Regentis Biomaterials Ltd.

Follow Regentis Biomaterials Ltd. into a list and get an email when it puts out news.

Share price · AMEX:RGNT

$1.49 USD +0.02 (+1.4%)

Close on Oct 21, 2026

Past 3 months -62.1% · daily closes, Jul 6, 2026 – Oct 21, 2026, adjusted for splits
Day range
$1.49 – $1.56 USDOct 21, 2026
Volume
14,161 sharesOct 21, 2026
Market cap
$10.47M USDAt the close on Oct 21, 2026 · price × 7.02M shares outstanding
Regentis Biomaterials Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE American:RGNT · Home$1.49 USD+0.02 (+1.4%)14,161$1.51$1.559$1.49$1.47Close on Oct 21, 2026

Daily closes

Last 3 months, Jul 21, 2026 – Oct 21, 2026 · AMEX:RGNT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.49+0.02+1.4%$1.51$1.559$1.4914,161
$1.47-0.01-0.7%$1.53$1.54$1.4713,662
$1.48-0.01-0.7%$1.46$1.60$1.4635,694
$1.49-0.06-3.9%$1.60$1.60$1.4623,490
$1.55+0.04+2.6%$1.55$1.56$1.5014,022
$1.51-0.115-7.1%$1.65$1.65$1.45132,565
$1.625-0.005-0.3%$1.63$1.67$1.5933,392
$1.63+0.03+1.9%$1.62$1.645$1.6036,336
$1.60-0.10-5.9%$1.67$1.74$1.6022,213
$1.70+0.07+4.3%$1.69$1.73$1.65173,958
$1.63-0.02-1.2%$1.64$1.69$1.6317,000
$1.65-0.02-1.2%$1.67$1.74$1.6534,000
$1.67-0.18-9.7%$1.83$1.86$1.66109,500
$1.85+0.02+1.1%$1.85$1.874$1.7829,000
$1.83+0.02+1.1%$1.86$1.88$1.809,000
$1.81-0.04-2.2%$1.87$1.98$1.8122,200
$1.85-0.04-2.1%$1.92$1.92$1.8058,600
$1.89-0.09-4.5%$1.95$1.97$1.8557,600
$1.98-0.06-2.9%$2.06$2.08$1.9017,200
$2.04-0.06-2.9%$2.08$2.08$2.0025,000
$2.10+0.01+0.5%$2.135$2.15$2.0515,100
$2.09-0.14-6.3%$2.17$2.17$2.0941,200
$2.23+0.42+23.2%$1.85$2.48$1.85440,400
$1.81+0.06+3.4%$1.80$1.89$1.7322,800
$1.75-0.05-2.8%$1.82$1.87$1.7520,607
$1.80-0.01-0.6%$1.81$1.85$1.7427,400
$1.81-0.07-3.7%$1.89$1.89$1.75194,400
$1.88-0.01-0.5%$1.90$1.96$1.87516,600
$1.89-0.07-3.6%$2.02$2.02$1.8916,542
$1.96-0.05-2.5%$2.01$2.01$1.91512,800
$2.01-0.03-1.5%$2.06$2.07$1.9810,500
$2.04+0.07+3.6%$2.00$2.04$1.9255,800
$1.970.000.0%$1.94$2.00$1.9415,900
$1.97-0.05-2.5%$2.06$2.06$1.9454,300
$2.02-0.04-1.9%$2.05$2.09$2.0214,500
$2.06+0.02+1.0%$2.04$2.11$2.00538,500
$2.04+0.04+2.0%$2.00$2.14$2.0024,400
$2.00-0.06-2.9%$2.10$2.10$2.0019,636
$2.06-0.01-0.5%$2.12$2.12$2.068,200
$2.07-0.02-1.0%$2.08$2.155$2.0419,100
$2.09-0.07-3.2%$2.10$2.14$2.0019,800
$2.16+0.06+2.9%$2.15$2.18$1.9625,600
$2.10+0.04+1.9%$2.05$2.17$2.0537,200
$2.06-0.17-7.6%$2.14$2.22$2.0646,000
$2.23+0.24+12.1%$2.00$2.47$1.98197,700
$1.99-0.05-2.5%$1.99$2.03$1.9551,600
$2.04+0.04+2.0%$2.04$2.065$2.0151,000
$2.00+0.10+5.3%$1.91$2.03$1.9055,100
$1.90-0.04-2.1%$1.96$2.01$1.9029,300
$1.94+0.10+5.4%$1.80$1.97$1.8045,600
$1.84-0.01-0.5%$1.86$1.93$1.8241,896
$1.85-0.04-2.1%$1.84$1.905$1.8019,900
$1.89-0.08-4.1%$2.04$2.04$1.85543,400
$1.97-0.10-4.8%$2.06$2.06$1.9736,400
$2.07+0.01+0.5%$2.06$2.27$1.98112,300
$2.06+0.19+10.2%$1.87$2.149$1.87115,700
$1.87+0.13+7.5%$1.74$1.99$1.70146,400
$1.74-0.06-3.3%$1.79$1.907$1.73128,900
$1.80+0.02+1.1%$1.81$1.88$1.7768,300
$1.780.000.0%$1.78$1.87$1.72353,100
$1.78-0.28-13.6%$2.00$2.00$1.721121,100
$2.06+0.10+5.1%$2.00$2.18$1.9867,600
$1.96+0.01+0.5%$2.00$2.06$1.93571,900
$1.95-0.08-3.9%$2.04$2.11$1.88543,200
$2.03-0.01-0.5%$2.08$2.19$2.025116,100
$2.04+0.04+2.0%$2.00$2.06$1.70188,400
Ticker
NYSE American:RGNT
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NYSE American
Currency
USD

What changed lately

Latest news

Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal

Oct 12, 2026

Closed $1.63 (+1.9%) on Oct 12, 2026

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

Sep 11, 2026

Closed $1.89 (-3.6%) on Sep 11, 2026

Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology

Jul 20, 2026

Closed $2.00 (-16.0%) on Jul 20, 2026

Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process

Jul 16, 2026

Closed $2.22 (-8.6%) on Jul 16, 2026

Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch

Jul 15, 2026

Closed $2.43 (-4.3%) on Jul 15, 2026

Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement

Jun 17, 2026

Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate

Jun 8, 2026

Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones

Jun 1, 2026

Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant

May 29, 2026

Amendment to Annual Report by Foreign Issuer (Form 20-F/A)

Feb 27, 2026

All Regentis Biomaterials Ltd. news

Decks

Regentis Biomaterials Ltd. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
12 in the last 12 months · 12 in all · newest Oct 12, 2026 · oldest 2025
Decks
4 decks · latest September 2026

Where Regentis Biomaterials Ltd. is listed

ListingExchangeCountryCurrency
NYSE American:RGNT · Home listing · This pageNYSE AmericanUnited StatesUSD
BOATS:RGNTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Regentis Biomaterials Ltd.